Pharsight

Drugs that contain Crofelemer

1. Mytesi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7341744 NAPO PHARMS INC Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
Jun, 2022

(1 year, 9 months ago)

US9585868 NAPO PHARMS INC Methods and compositions for treating HIV-associated diarrhea
Oct, 2031

(7 years from now)

US8962680 NAPO PHARMS INC Methods and compositions for treating HIV-associated diarrhea
Oct, 2031

(7 years from now)

Market Authorisation Date: 31 December, 2012

Treatment: Symptomatic relief of non-infectious diarrhea

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

MYTESI family patents

Family Patents